NYSE:OGN
PT. Organon Pharma Indonesia Tbk.
- Stock
Last Close
6.71
06/11 22:31
Market Cap
5.12B
Beta: -
Volume Today
29.84M
Avg: 2.10M
PE Ratio
7.03
PFCF: 9.70
Dividend Yield
6.96%
Payout:50.26%
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | 992M - | 914M 7.86% | 959M 4.92% | 1.16B 20.86% | |||
average payables | 258.50M - | 820.50M 217.41% | 1.26B 53.20% | 1.22B 2.70% | |||
average receivables | 1.29B - | 1.24B 4.07% | 1.43B 15.48% | 1.61B 12.67% | |||
book value per share | 27.79 - | -3.24 111.66% | -5.95 83.61% | -3.51 40.98% | -0.27 92.22% | ||
capex per share | -0.40 - | -0.36 8.91% | -1.10 202.17% | -1.92 75.26% | -1.68 12.69% | -0.98 41.72% | |
capex to depreciation | -0.06 - | -0.28 357.63% | -1.77 540.92% | -2.50 41.33% | -2.01 19.52% | -1.07 46.74% | |
capex to operating cash flow | -0.03 - | -0.03 21.38% | -0.13 282.31% | -0.20 56.19% | -0.50 150.67% | -0.31 36.88% | |
capex to revenue | -0.01 - | -0.01 14.51% | -0.03 190.27% | -0.08 125.44% | -0.07 10.66% | -0.04 42.05% | |
cash per share | 1.26 - | 1.98 56.74% | 2.91 47.16% | 2.78 4.41% | 2.70 2.68% | ||
days of inventory on hand | 171.91 - | 99.57 42.08% | 140.21 40.82% | 159.59 13.82% | 190.84 19.59% | ||
days payables outstanding | 41.41 - | 28.24 31.80% | 211.77 649.76% | 180.11 14.95% | 190.70 5.88% | ||
days sales outstanding | 69.79 - | 49.23 29.46% | 80.02 62.53% | 87.20 8.98% | 101.64 16.56% | ||
debt to assets | 0.01 - | 0.86 - | 0.81 4.86% | 0.73 10.71% | |||
debt to equity | 0.01 - | -6.06 - | -9.99 64.97% | -125.14 1,152.41% | |||
dividend yield | 0.02 - | 0.04 117.58% | 0.08 94.68% | ||||
earnings yield | 0.26 - | 0.38 49.47% | 0.26 32.88% | 0.17 31.81% | 0.13 26.16% | 0.28 114.23% | |
enterprise value | 8.20B - | 7.92B 3.47% | 16.12B 103.59% | 15.30B 5.05% | 11.76B 23.14% | ||
enterprise value over ebitda | 1.96 - | 2.63 34.22% | 8.88 237.37% | 9.06 1.92% | 7.57 16.36% | ||
ev to operating cash flow | 2.96 - | 3.62 22.12% | 6.56 81.14% | 17.84 172.02% | 14.72 17.46% | ||
ev to sales | 1.05 - | 0.98 7.28% | 2.56 161.46% | 2.48 3.05% | 1.88 24.23% | ||
free cash flow per share | 14.17 - | 10.57 25.40% | 7.54 28.64% | 7.77 3.03% | 1.70 78.17% | 2.14 26.06% | |
free cash flow yield | 0.43 - | 0.32 25.40% | 0.23 28.64% | 0.26 12.50% | 0.06 76.20% | 0.15 144.17% | |
graham net net | -6.10 - | -37.45 514.19% | -39.28 4.89% | -37.52 4.47% | -36.95 1.52% | ||
graham number | 89.16 - | 24.94 72.03% | 26.70 7.08% | 16.88 36.77% | 4.95 70.66% | ||
income quality | 1.71 - | 0.84 51.13% | 1.01 20.97% | 1.82 79.69% | 0.94 48.57% | 0.78 16.53% | |
intangibles to total assets | 0 - | 0.49 Infinity% | 0.49 0.20% | 0.49 0.52% | 0.48 2.54% | 0.43 11.15% | |
interest coverage | 6.28 - | 3.50 44.19% | 2.50 28.54% | ||||
interest debt per share | 0.41 - | 37.04 - | 36.74 0.82% | 36.24 1.36% | |||
inventory turnover | 2.12 - | 3.67 72.66% | 2.60 28.99% | 2.29 12.14% | 1.91 16.38% | ||
invested capital | 0.01 - | -6.06 - | -9.99 64.97% | -125.14 1,152.41% | |||
market cap | 8.42B - | 8.42B 0% | 8.42B 0% | 7.72B 8.27% | 7.10B 8.08% | 3.70B 47.93% | |
net current asset value | 442M - | -7.82B 1,869.23% | -8.43B 7.79% | -7.92B 6.09% | -7.62B 3.74% | ||
net debt to ebitda | -0.05 - | -0.17 223.38% | 4.63 2,882.95% | 4.86 4.91% | 5.19 6.97% | ||
net income per share | 8.51 - | 12.71 49.47% | 8.53 32.88% | 5.33 37.55% | 3.61 32.27% | 3.99 10.61% | |
operating cash flow per share | 14.57 - | 10.93 24.95% | 8.64 20.96% | 9.69 12.21% | 3.38 65.17% | 3.12 7.67% | |
payables turnover | 8.81 - | 12.92 46.62% | 1.72 86.66% | 2.03 17.57% | 1.91 5.55% | ||
receivables turnover | 5.23 - | 7.41 41.76% | 4.56 38.47% | 4.19 8.24% | 3.59 14.21% | ||
research and ddevelopement to revenue | 0.04 - | 0.03 24.23% | 0.04 32.74% | 0.07 87.15% | 0.08 8.56% | 0.09 12.18% | |
return on tangible assets | 0.60 - | 0.41 32.27% | 0.25 38.59% | 0.16 35.41% | 0.15 8.09% | ||
revenue per share | 38.62 - | 30.72 20.46% | 31.98 4.10% | 24.86 22.26% | 24.30 2.27% | 24.44 0.58% | |
roe | 0.46 - | -2.63 675.86% | -0.90 65.99% | -1.03 14.75% | -14.61 1,321.59% | ||
roic | 0.48 - | -2.80 680.95% | 0.19 106.70% | 0.15 19.72% | 0.23 53.20% | ||
sales general and administrative to revenue | |||||||
shareholders equity per share | 27.79 - | -3.24 111.66% | -5.95 83.61% | -3.51 40.98% | -0.27 92.22% | ||
stock based compensation to revenue | 0.01 - | 0.01 7.96% | 0.01 26.52% | 0.01 40.32% | 0.01 29.80% | 0.02 32.75% | |
tangible asset value | 1.86B - | -5.93B 418.09% | -6.76B 14.11% | -6.14B 9.14% | -5.21B 15.27% | ||
tangible book value per share | 7.36 - | -23.41 418.09% | -26.67 13.92% | -24.18 9.33% | -20.31 15.99% | ||
working capital | 2.61B - | 2.23B 14.58% | 1.16B 47.92% | 1.42B 22.01% | 1.59B 12.05% |
All numbers in USD (except ratios and percentages)